SMTL ID : 7a6f.1

Nanodisc reconstituted human ABCB1 in complex with MRK16 Fab and zosuquidar

Coordinates

PDB Format Compare

Method

ELECTRON MICROSCOPY

Oligo State

hetero-1-1-1-mer

Ligands

2 x ZQU: Zosuquidar(Non-covalent)

ZQU.1: 17 residues within 4Å: Chain A: L.65, I.299, F.303, I.306, Y.310, F.336, L.339, I.340, F.343, S.344, Q.725, F.770, A.987, Q.990, V.991, F.994 Ligands: ZQU.2 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:L.65, A:F.336, A:L.339, A:F.770, A:Q.990 Hydrogen bonds: A:Q.990 pi-Stacking: A:F.303 ZQU.2: 17 residues within 4Å: Chain A: L.65, A.229, W.232, A.233, L.236, I.306, Q.347, E.875, M.876, L.879, M.949, Y.950, Y.953, F.983, M.986, Q.990 Ligands: ZQU.1 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:L.65, A:A.233, A:L.236, A:Q.347, A:Y.950 Hydrogen bonds: A:Y.953 Salt bridges: A:E.875, A:E.875 pi-Stacking: A:W.232, A:W.232

8 x CLR: CHOLESTEROL(Non-covalent)

CLR.3: 6 residues within 4Å: Chain A: A.220, I.221, V.224, L.312, W.315 Ligands: CLR.4 4 PLIP interactions: 4 interactions with chain A Hydrophobic interactions: A:A.220, A:I.221, A:L.312, A:W.315 CLR.4: 10 residues within 4Å: Chain A: I.221, A.308, A.311, L.312, W.315, N.753, S.756, L.757, L.760 Ligands: CLR.3 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:I.221, A:A.311, A:W.315, A:L.757, A:L.760, A:L.760 CLR.5: 5 residues within 4Å: Chain A: I.719, G.723, A.727, I.730, L.758 4 PLIP interactions: 4 interactions with chain A Hydrophobic interactions: A:I.719, A:A.727, A:I.730, A:I.730 CLR.6: 5 residues within 4Å: Chain A: Q.856, L.859, L.860, A.863, F.959 4 PLIP interactions: 4 interactions with chain A Hydrophobic interactions: A:Q.856, A:L.859, A:L.860, A:F.959 CLR.7: 5 residues within 4Å: Chain A: L.860, I.864, G.955, R.958 Ligands: CLR.8 4 PLIP interactions: 4 interactions with chain A Hydrophobic interactions: A:L.860, A:I.864, A:I.864, A:R.958 CLR.8: 4 residues within 4Å: Chain A: T.112, A.115, F.951 Ligands: CLR.7 3 PLIP interactions: 3 interactions with chain A Hydrophobic interactions: A:A.115, A:F.951 Hydrogen bonds: A:T.112 CLR.9: 6 residues within 4Å: Chain A: N.839, I.840, L.843, I.847, S.992 Ligands: CLR.10 5 PLIP interactions: 5 interactions with chain A Hydrophobic interactions: A:N.839, A:I.840, A:L.843, A:I.847 Hydrogen bonds: A:S.992 CLR.10: 6 residues within 4Å: Chain A: L.843, L.862, A.869, I.870, V.873 Ligands: CLR.9 5 PLIP interactions: 5 interactions with chain A Hydrophobic interactions: A:L.843, A:L.862, A:A.869, A:I.870, A:V.873

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Nosol, K. et al., Cryo-EM structures reveal distinct mechanisms of inhibition of the human multidrug transporter ABCB1. Proc.Natl.Acad.Sci.USA (2020)

Release Date

2020-10-14

Peptides

Multidrug resistance protein 1: A
MRK16 Fab-fragment light chain: B
MRK16 Fab-fragment heavy chain: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
C

Membrane

We predict this structure to be a membrane protein.
Show / Hide

Multidrug resistance protein 1

MRK16 Fab-fragment light chain

MRK16 Fab-fragment heavy chain

Related Entries With Identical Sequence